SUSPENSION LETTER - MAILED
mailed
on 09 Sep 2024
Last Applicant/ Owned by
15TH FLOOR
NEW YORK
NY
10036
Serial Number
98095822 filed on 21st Jul 2023
Registration Number
N/A
Correspondent Address
Lisa L. Mueller
Filing Basis
No Filing Basis
Disclaimer
NO DATA
AURAYA
Pharmaceutical preparations for human use; biologicpreparations for medical and therapeutic purposes;pharmaceutical preparations to treat inflammatorydiseases and disorders and diseases and disorders ofthe immune system; pharmaceutical preparations to treatdermatomyositis, systemic lupus erythematosus (SLE),hidradenitis suppurativa, scleroderma, sarcoidosis,juvenile dermatomyositis, and non-infect Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for human use; biologicpreparations for medical and therapeutic purposes;pharmaceutical preparations to treat inflammatorydiseases and disorders and diseases and disorders ofthe immune system; pharmaceutical preparations to treatdermatomyositis, systemic lupus erythematosus (SLE),hidradenitis suppurativa, scleroderma, sarcoidosis,juvenile dermatomyositis, and non-infectious uveitis
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98095822
Mark Type
No Service/Collective Mark
Attorney Docket Number
No PRIOV-42929
44D Filed
Yes
44D Current
Yes
44E filed
Yes
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 09th Sep 2024 | SUSPENSION LETTER WRITTEN |
| 09th Sep 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| 09th Sep 2024 | LETTER OF SUSPENSION E-MAILED |
| 01st May 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| 01st Mar 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 01st Mar 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 01st Mar 2024 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| 01st Mar 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 01st Mar 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 01st Mar 2024 | NON-FINAL ACTION E-MAILED |